Potential Hydrogen-Bonding Stabilization of a Radical from Coenzyme B12
FULL PAPER
ESI-MS. HPLC solvents were 0.1% aqueous trifluoroacetic acid (A) and
methanol (B). HPLC analyses were performed on a Merck-Hitachi L-
7000 system that is equipped with a diode array UV/Vis spectrometer
and Macherey–Nagel Nucleosil C-18ec RP columns (particle size: 5 mm;
pore size: 100 ꢀ; 250ꢄ3 mm; flow rate: 0.5 mLminÀ1). Preparative
HPLC separations were performed on a Varian Prostar system equipped
with two Prostar 215 pumps, a Prostar 320 UV/Vis detector and Macher-
ey–Nagel Nucleosil C-18ec RP columns (particle size: 7 mm; pore size:
100 ꢀ; 250ꢄ40 mm; flow rate: 40 mLminÀ1). HPLC-ESI-MS spectra
were measured on a Bruker HCT spectrometer equipped with an Aquini-
ty UPLC (Waters) by using Nucleosil C-18ec RP columns (particle size:
5 mm; pore size: 100 ꢀ; 250ꢄ3 mm; flow rate: 0.3 mLminÀ1). HPLC-ESI-
MS solvents were 0.1% formic acid (A) and methanol (B). The following
gradient (A) was used for all HPLC, HPLC-ESI-MS, and preparative
HPLC measurements: 25% B for 5 min, then to 100% B over 25 min,
then 100% B for 10 min. The following gradient (B) was used only for
compound 4: 10% B for 2 min, then to 100% B over 10 min, then 100%
B for 13 min.
Cob(I)alamin: Compound 7 (10 mgmLÀ1) was reduced by using sodium
dithionite (1m) in D2O.[22] The samples were reoxidized in air (10 h) and
purified on a C18 column (see details above). For kinetic studies moni-
tored by MALDI-TOF-MS, the samples were first reoxidized with a
slight excess of potassium hexacyanoferrateACTHNUTRGNEUGN(III). The samples were
freeze-dried and redissolved in H2O for MALDI-TOF-MS. For NMR
spectroscopy, the samples were recrystallized from water/acetone (1:10).
The NMR samples in D2O were adjusted to pH 9 with a pH microelec-
trode.
X-ray crystal-structure determination: X-ray crystallographic data were
collected on an Oxford Diffraction Gemini A Ultra diffractometer at
150 K by using CuKa radiation (l=1.54184 ꢀ). Analytical numeric ab-
sorption corrections that use a multifaceted crystal model which is based
on expressions derived by R. C. Clark and J. S. Reid[39] were applied,
based on symmetry-equivalent and repeated reflections. Structures were
solved by direct methods and refined on all unique F2 values, with aniso-
tropic non-H atoms and constrained riding isotropic H atoms. High ani-
sotropy of some atoms in solvent acetone molecules, which are present in
the crystal structure of R2b, indicate disorder, but this could not be re-
solved satisfactorily by split positions and has been ignored. Disordered
water molecules that could not be modeled as discrete atoms in R2b and
S2b were treated by the SQUEEZE procedure of PLATON.[40] Programs
used were CrysAlisPro for data collection, integration, and absorption
corrections,[41] and OLEX2[42] or SHELXTL[43] for structure solution, re-
finement, and graphics. Full details about crystallographic experimental
information is provided in the Supporting Information, together with a
list of bond lengths and angles. CCDC-864775 (R2b) and 864776 (S2b)
contain the supplementary crystallographic data for this paper. These
data can be obtained free of charge from The Cambridge Crystallograph-
All MALDI-TOF-MS measurements of the deuterium exchange experi-
ments were done on an Applied Biosystems 4800Plus MALDI-TOF/TOF
mass spectrometer. The samples were measured directly upon being dis-
solved in water and after 6 h to check for a difference in exchange. a-
Cyano-4-hydroxycinnamic acid in 50% acetonitrile (0.1% trifluoroacetic
acid in H2O) as a matrix was mixed in a dilution series (2-, 4-, 8-, 16-, 32-
fold) for sample preparation. Sheffield ChemPuter (webpage retrieved
on
html) was used to generate theoretical values of natural-abundance iso-
topic distribution patterns for MALDI-TOF-MS. The Data Explorer
from Applied Biosystems was used to process MALDI-TOF-MS data
and extract integrals of individual signals. The monoisotopic signal of un-
Enzymatic purification and assays for glutamate mutase kinetic studies:
Glutamate mutase (components S and E) from Clostridium cochlearium
was recombinantly produced and purified by following published proce-
dures.[11a] Methylaspartase was purified from cell-free extracts of Clostri-
dium tetanomorphum.[44] The components S and E were assembled into
the holoenzyme in the presence of 1 or 3, 4, and 5. A standard coupled
enzyme assay with methylaspartase was used for the measurement of glu-
tamate mutase kintetic parameters (378C, 50 mm Tris, pH 8.3, 0.05 mm
mercaptoethanol). The assays for enzymatic activity were performed by
using component E (GlmE) and a 14-fold excess of component S (GlmS)
together with the cofactor analogue at varying concentrations. All alkyl-
cobalamins (1, 3, 4, and 5) were shielded from light and measurements
were performed under a protective red light. The initial specific activities
of the partially purified enzymes were: methylaspartase (44 UmgÀ1),
GlmS (66 UmgÀ1), and GlmE (18 UmgÀ1). The specific activity of GlmS
was determined by using an excess of GlmE, and vice versa. When meas-
uring KM and Vmax for 5’-deoxyadenosylcobalamin (1), GlmS (5 mg),
GlmE (2.6 mg), methylaspartase (36 mg), and glutamic acid (20 mm) were
used, and the cofactor concentration was varied (0.32 mm–25 mm). In the
case of cobalamin derivatives 3, 4, and 5, ten times the amount of apo-
glutamate mutase was used. 3’,5’-Dideoxyadenosylcobalamin (4) concen-
trations were varied between 0.35 mm and 70 mm. The concentration of
component E was used to calculate kcat for compounds 1 and 4. After
mixing all ingredients together, the cuvette was incubated for 5 min at
378C to ensure the formation of the holoenzyme composed of E, S, and
either 1 or one of the analogues 3, 4, or 5. Then the reaction was started
with (S)-glutamate, and the formation of (2S,3S)-methylaspartate was
measured continuously at 240 nm by conversion to mesaconate by using
mesaconase as an auxiliary enzyme. In this assay, the inclusion of 1 or
the analogue had two different functions: the assembly of the holoen-
zyme, and the action as a cofactor for catalysis.
labeled cobACHTUNGTRENNUNG(III)alamin without an upper ligand was used to calculate its
whole isotopic distribution pattern (based on natural abundance and a
reference measurement of unlabeled hydroxocobalamin; see the Support-
ing Information, Table S1). This was then subtracted from the signals
with higher mass to reveal the pattern caused by +1 Da labeled cob-
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
ACHTUNGTRENNUNG
the Supporting Information). All other mass spectra were recorded
either in the positive or negative mode on an Esquire HCT from Bruker
(Bremen, Germany).
Deuterium exchange of cobalamins under reducing conditions:
Cob(II)alamin reduction with dithiothreitol (DTT): Hydroxocobalamin
(HOCbl, 7, 10 mgmLÀ1) was reduced by using DTT (0.1m) in D2O. The
reoxidation was done by using potassium hexacyanoferrateACTHNUTRGENUGN(III) (0.2m) in
D2O. For analysis, the samples were desalted on C18 columns (Sep-Pak
Vac from Waters). The columns were conditioned with methanol, equili-
brated with D2O, loaded with solutions of the sample in D2O, and then
eluted with acetonitrile in D2O (50%). The samples were freeze-dried
and suspended in H2O prior to MALDI-TOF-MS measurements. Initial-
ly, the samples were dissolved in D2O and used for NMR spectroscopy,
but no clear spectra could be obtained. Additional purification by using
HPLC (RP18 reverse-phase semipreparative column, solution gradient of
0 to 80% acetonitrile in H2O) or recrystallization from water/acetone
(1:10) did not lead to sufficiently clear NMR spectra.
Cob(II)alamin reduction with PtO2/H2: Compound 7 (10 mgmLÀ1) was
stirred with PtO2 (0.5 mgmLÀ1) under a H2/N2 atmosphere (5%). For re-
oxidation, the catalyst was filtered off and the sample was incubated in
air (10 h). No further purification for NMR analysis was needed. For
MALDI-TOF-MS, the samples were freeze-dried and dissolved in H2O.
Cob(II)alamin generation by photolysis: 5’-Deoxyadenosylcobalamin (1,
10 mgmLÀ1) in D2O was irradiated for 6 h (120 W incandescent light
bulb) for three successive days in an NMR tube in an anaerobic chamber.
The control sample was kept in the dark under air. After reoxidation in
air (10 h), no further purification was done for NMR analysis and
MALDI-TOF-MS.
Acknowledgements
We are indebted to Professor Christoph Kratky, Graz, Austria for provid-
ing the crystal structure presented in Figure 5. We thank the German Re-
Chem. Eur. J. 2012, 18, 16114 – 16122
ꢃ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
16121